Trial Profile
An Open Label Extension, Investigator Initiated Trial to Examine Radiographic Progression , Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis. EASIC (European Ankylosing Spondylitis Infliximab Cohort).
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Aug 2019
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Acronyms EASIC
- 08 Aug 2019 This trial has been completed in UK - MHRA (On 2011-09-15), according to European Clinical Trials Database.
- 25 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to results published.
- 25 Mar 2016 Results of extension study (n=71) of this trial were published in the Clinical and Experimental Rheumatology.